| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Chief Development Officer | See Remarks
1 company
Michaelson Jennifer is a Chief Scientific Officer at Cullinan Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $1.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 19, 2025 | CGEM Cullinan Therapeutics, Inc. | Chief Scientific Officer | Sell | 1,345 | $10.01 | $13,463.45 | -1.0% | +35.1% | - | |
| Dec 18, 2025 | CGEM Cullinan Therapeutics, Inc. | Chief Scientific Officer | Sell | 2,898 | $9.67 | $28,023.66 | -2.1% | +31.6% | - | |
| Dec 15, 2025 | CGEM Cullinan Therapeutics, Inc. | Chief Scientific Officer | Sell | 3,143 | $12.23 | $38,432.74 | -1.1% | +29.7% | - | |
| Nov 24, 2025 | CGEM Cullinan Therapeutics, Inc. | Chief Scientific Officer | Sell | 4,000 | $12.30 | $49,200.00 | -2.8% | +8.2% | - | |
| Feb 25, 2025 | CGEM Cullinan Therapeutics, Inc. | Chief Scientific Officer | Sell | 3,756 | $8.53 | $32,038.68 | -2.6% | -8.6% | +67.8% | |
| Jan 6, 2025 | CGEM Cullinan Therapeutics, Inc. | Chief Scientific Officer | Sell | 4,000 | $12.51 | $50,040.00 | -4.0% | -38.5% | -13.8% | |
| Dec 18, 2024 | CGEM Cullinan Therapeutics, Inc. | Chief Scientific Officer | Sell | 4,693 | $11.41 | $53,547.13 | -4.5% | -17.1% | -7.3% | |
| Dec 12, 2024 | CGEM Cullinan Therapeutics, Inc. | Chief Scientific Officer | Sell | 3,489 | $12.52 | $43,682.28 | -3.2% | -25.6% | -2.3% | |
| Nov 5, 2024 | CGEM Cullinan Therapeutics, Inc. | Chief Scientific Officer | Sell | 8,000 | $15.64 | $125,120.00 | -6.9% | -37.0% | -54.3% | |
| Sep 5, 2024 | CGEM Cullinan Therapeutics, Inc. | Chief Scientific Officer | Sell | 8,000 | $18.09 | $144,720.00 | -6.5% | -27.7% | -61.0% |